The Barchart Chart of the Day belongs to Axon (AAXN) I found the Taser stock by using Barchart to sort a list of the fastest revenue growth stocks first by the Highest Weighted Alpha then by technical buy signals of 80% or more. Next, I used the Flipchart feature to review the charts for consistent price appreciation over the…
We are at the tail end of the Q1 earnings season as all sectors save retail have reported. The retail sector has seen about half of its total releases. Total earnings for the sector reported so far are up 26.1% on 14.9% revenue growth with 68.4% companies beating EPS estimates and 63.2% beating revenue estimates. While the…
TM editors’ note: This article discusses a nano cap. Such stocks are easily manipulated; do your own careful due diligence. Thinly traded nano-cap Amedica (AMDA) is a biomaterial company that develops and commercializes silicon nitride for biomedical applications. The stock has been trading with massive volatility lately and we wanted to bring it to your attention because we…
Over the weekend, we showed why according to Macquarie strategist Viktor Shvets, the “biggest risk facing investors over the next 12 months” was an intense appreciation in the US dollar. The key reason behind the thesis was simple: a sharp reduction in dollar supply has been observed as the Fed destroys liquidity by shrinking its balance…
ZTE is back from the dead after Trump reversed sanctions. It’s easy to explain why, but politicians are angry. Yesterday I reported ZTE Back From the Dead After Trump Reverses Sanctions. All of a sudden Trump is concerned about Chinese jobs. President Xi of China, and I, are working together to give massive Chinese phone company,…
Shares of Xerox Corp. (XRX) are falling after the company announced the termination of its deal with Fujifilm (FUJIY) and a new settlement agreement with billionaire investors Carl Icahn and Darwin Deason. FUJIFILM DEAL TERMINATED: On Sunday, Xerox announced that it notified Fujifilm that the agreement to combine Xerox with Fuji Xerox is being terminated…
Biotechs Soar And Find Relief After Trump Big Speech Look to MId-Caps for Momentum Large Caps are Value Stocks Gene Editing and Gene Therapy Provides New Theme Biotechs soared Friday immediately after Trump’s much-anticipated new drug plan speech which was going to address high drug prices and potentially bring more government intervention. The big concern…
Join Sophie Antal Gilbert, a Consulting Director at Russell Investments and Rob Kuharic an Investment Strategist for Tax-Managed, at Russell Investments, as they explore the 6 most common questions we hear from advisors about tax-smart investing.
That’s the law. OK, maybe not (unless you take all your legal counsel from bumper stickers). But there does seem to be one market law these days, which is that on those rare occasions when selling is allowed to take place, the S&P 500 shall go NO LOWER than its 200-day exponential moving average. Keep this…
The good news is: The secondaries outperformed the blue chips again last week. The Negatives The market is overbought. The Dow Jones Industrial Average (DJIA) has been up for 7 consecutive days and the Russell 2000 (R2K) has been up for 6 consecutive days. Seasonality for the coming week has been, on average, negative. The…
